SCHEMBL7652479

SCHEMBL7652479

O=C(OCc1ccccc1)c1ccc(Oc2c(F)c(F)c(-c3c(F)c(F)c(Oc4ccc([N+](=O)[O-])c(OCc5ccccc5)c4)c(F)c3F)c(F)c2F)cc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.43
RAB9A P51151 2/20 0.43
ALDH1A1 P00352 1/20 0.43
MYC P01106 1/20 0.42
MAX P61244 1/20 0.42
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
NPC1 O15118 1/20 0.39
ATM Q13315 1/20 0.39
CTSV O60911 3/20 0.39
CTSL P07711 3/20 0.39
MITF O75030 1/20 0.39
ABCB1 P08183 1/20 0.39
BACE1 P56817 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7651791 0.90 MAPT (0.40) MAPTRAB9AALDH1A1MYCMAX
SCHEMBL7654964 0.89 MAPT (0.49) MAPTRAB9AALDH1A1MYCMAX
SCHEMBL4623468 0.89 MEN1 (0.45) MAPTRAB9AMYCMAXKMT2A
SCHEMBL7657358 0.88 KMT2A (0.42) MAPTRAB9AALDH1A1MYCMAX
SCHEMBL7152823 0.84 MAPT (0.43) MAPTRAB9AALDH1A1MYCMAX
SCHEMBL7795531 0.83 CTSV (0.43) MAPTRAB9AALDH1A1MYCMAX
SCHEMBL7548709 0.82 MEN1 (0.44) MAPTRAB9AMYCMAXKMT2A
SCHEMBL7652342 0.82 KMT2A (0.56) MAPTRAB9AALDH1A1KMT2AMEN1
SCHEMBL30892476 0.81 MYC (0.55) MAPTRAB9AALDH1A1MYCMAX
SCHEMBL7342938 0.81 MYC (0.55) MAPTRAB9AALDH1A1MYCMAX

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0905170-B1 Polybenzoxazoles and polybenzothiazoles precursors QIMONDA AG (DE) 2013-10-30 EP disclosed
US-6437178-B2 REACTING A HALOGENATED BENZENE COMPOUND WITH NITRO(THIO)PHENOL; REDUCTION INFINEON TECHNOLOGIES AG (DE) 2002-08-20 US disclosed
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid SIEMENS AKTIENGESELLSCHAFT 2001-12-27 US disclosed
EP-0905123-B1 o-amino(thio)phenol-carboxylic acids and their preparation INFINEON TECHNOLOGIES AG (DE) 2001-12-12 EP disclosed
US-6310238-B1 INTERMEDIATES FOR THE PREPARATION OF POLYBENZOXAZOLES AND POLYBENZOTHIAZOLES SIEMENS AKTIENGESELLSCHAFT (DE) 2001-10-30 US disclosed
US-6120970-A Polybenzoxazole and polybenzothiazole precursors SIEMENS AKTIENGESELLSCHAFT (DE) 2000-09-19 US disclosed
EP-0905123-A1 o-amino(thio)phenol-carboxylic acids and their preparation SIEMENS AKTIENGESELLSCHAFT (DE) 1999-03-31 EP disclosed
EP-0905170-A2 Polybenzoxazoles and polybenzothiazoles precursors SIEMENS AKTIENGESELLSCHAFT (DE) 1999-03-31 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010056203-A1 O-aminophenolcarboxylic acid and o-aminothiophenolcarboxylic acid TPMT, PAH, AADAT MAPT 3652/4885RAB9A 4769/4885ALDH1A1 424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.